Circulating CD137⁺Treg cells and LOX-1⁺PMN-MDSCs as biomarkers of immunotherapy resistance in (R/M) HNSCC patients
Abstract Background Recurrent/metastatic head and neck squamous cell carcinoma ((R/M) HNSCC) represents one of the most aggressive and immunosuppressive cancers. Despite the introduction of immune checkpoint inhibitors (ICIs), only a limited number of patients obtain long-term benefits. In (R/M) HNS...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2025-12-01
|
| Seria: | Journal of Experimental & Clinical Cancer Research |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s13046-025-03574-6 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|